（来源：劳动午报） 富含果糖食物 果糖为亲水物质，相比于纯水，含有少量果糖的水可以延缓水吸收速度，从而使身体更 好留住水。水果中含有不少果糖，比如葡萄、梨、香蕉、柿子等。 富含优质油脂的食物 适量的优质脂肪能够让皮肤保持柔嫩光滑。摄入坚果和籽类物质可以给身体补充 这类油脂，比如核桃、芝麻酱等。需要提醒的是，这类食物不能吃太多，以免发胖。 （刘畅） 转自：劳动午报 冬天室外风大，室内温度高，很多人被皮肤干燥困扰。除了选择合适的护肤品，吃对食物也有助缓解皮 肤干燥。 富含维生素A食物 维生素A缺乏表现为表皮干燥而角质化，毛囊突起，皮肤摸起来粗糙而扎手，甚至眼 睛也会发干。维生素A是脂溶性维生素，存在于肝脏、肾脏以及富含脂肪的海鱼中。推荐胡萝卜、南 瓜、菠菜、芥蓝、小油菜等。 富含维生素B2食物 如果缺少这种维生素，会诱发唇炎、口角炎、鼻及脸部的脂溢性皮炎等。维生素B2 广泛存在于奶类、蛋类、各种肉类、动物内脏、谷类、蔬菜和水果等食物中。 富含维生素C的果蔬 维生素C可以清除自由基，帮助人体更好地吸收食物中的铁元素，并在体内参与胶 原蛋白的合成，对于提升肤色和维护皮肤的娇嫩有着不可或缺的作用。平时吃一些鲜枣、甜椒、 ...

来源：青岛日报 从小到大，几乎人人都吃过"胶囊"这类药物。服药时，一杯热水十分贴心，但在医生看来，"用热水送 服胶囊"反而是个危险的操作。一起来看专家解读其中的原因，并提醒你哪些药物不宜热水送服。 吃胶囊药不要用热水送服 专家介绍，胶囊是临床常见的药物剂型，约占医生开具处方的20%，但它有个弱点——怕热水。 根据胶囊"囊材"的不同，可分为明胶胶囊和植物胶囊。其中，明胶是应用最多的成囊材料，这是一种蛋 白质制品，成分中85%~90%为蛋白质，不溶于冷水，但容易在温水和热水中溶解。 有试验发现，胶囊在50℃的水里浸泡10秒钟，就会变软、变黏稠。哪怕胶囊外壳只是化了一部分，也会 变得像粘了一块泡泡糖一样，拉丝、发黏。 胶囊长时间和食管接触、在错误位置溶解、药物提前释放，可能会带来以下健康风险。 如果因为水温过高破坏了结构,药物就无 法按预期到达肠道发挥应有的作用,还可 能对胃黏膜造成较强的刺激。 引发不良后果 有些胶囊属于缓释、控释型的,需要缓 慢、平稳地释放,一旦外壳提前破坏或掰 开服用,可能产生突释等不良反应。 专家提醒,尤其是软胶囊剂,药典要求存放温度 是8℃~20℃。存放温度过高或用热水送服,容易 导致粘连 ...

从小到大，几乎人人都吃过"胶囊"这类药物。服药时，一杯热水十分贴心，但在医生看来，「用热水送 服胶囊」反而是个危险的操作。 损伤食管 若胶囊粘在食管，可能在食管局部形成高渗环境，造成灼伤，甚至引发药物性食管炎。 尤其当胶囊内包裹的是刺激性较强、气味浓烈的药物时，如多西环素、利福平、布洛芬、双仑磷酸钠 等，若外壳提前受损，更易刺激食管。 2 《生命时报》邀请专家解读其中的原因，并提醒你哪些药物不宜热水送服。 吃胶囊药，不要用热水送服 上海交通大学医学院附属瑞金医院药剂科副主任石浩强介绍，胶囊是临床常见的药物剂型，约占医生开 具处方的20%，但它有个弱点——怕热水。 根据胶囊"囊材"的不同，可分为明胶胶囊和植物胶囊。其中，明胶是应用最多的成囊材料，这是一种蛋 白质制品，成分中85%~90%为蛋白质，不溶于冷水，但容易在温水和热水中溶解。 有试验发现，胶囊在50℃的水里浸泡10秒钟，就会变软、变黏稠。哪怕胶囊外壳只是化了一部分，也会 变得像粘了一块泡泡糖一样，拉丝、发黏。 胶囊长时间和食管接触、在错误位置溶解、药物提前释放，可能会带来以下健康风险。 1 伤胃 有些胶囊是肠溶的，胶囊作为保护壳一路"护送"药物进入肠道 ...

"提升免疫力是一场围绕肠道的长期工程，不是靠某种补品就能速成的。" 最后，何奕提醒，如果 长期疲劳、体重下降、排便习惯持续异常，请及时到消化专科就诊。（实习生闫炜对此文亦有贡献） 没力气、易生病，总觉得免疫力差？天天吃维生素C、补品，免疫力还是上不去？答案藏在肠道 里！湖南省肿瘤医院消化肿瘤内科主任医师何奕表示，约70%的免疫细胞都驻扎在肠道，肠道才是免疫 力的"主战场"，只顾着补、不顾着养，再好的补品效果也不能持久。 ...

155亿身家的医药富豪，又要去港股上市了。 12月10日，国内知名制药企业石药集团旗下的石药创新制药股份有限公司，正式在港交所递交招股书， 准备赴港上市。 来源：南财社 而在2019年，石药创新就已经在深圳创业板上市，证券代码为"新诺威"。截至12月11日收盘，新诺威股 价33.84元/股，市值475亿元。 近年来，新诺威从石药集团旗下的原料药平台开始通过购入巨石生物等石药集团其他子公司，实现向创 新药领域转型。据招股书披露，2025年11月，石药创新以11亿人民币对价，从恩必普药业收购巨石生物 额外29%的股权。收购后，石药创新于巨石生物的所有权权益增至80%。 从业绩来看，新诺威的赴港上市的背后，是传统业绩的失速，以及创新药转型的阵痛。不仅业绩连续下 滑，净利润更是由盈转亏，并且亏损还在持续扩大。 值得一提的是，一个月前，这家公司刚因为公司多名前高管因巨额内幕交易被监管集体重罚，受到市场 瞩目。 2022-2024年，其营收分别为28.38亿元、25.39亿元、19.81亿元，出现逐年下滑的趋势。毛利分别为 13.28亿元、11.58亿元、8.29亿元；期内利润分别为2.94亿元、1.26亿元、-3亿元， ...

Core Insights - The company reported a decline in revenue and net profit for the first three quarters of 2025, with total revenue at RMB 19.89 billion, down 12.3% year-on-year, and net profit attributable to shareholders at RMB 3.511 billion, down 7.1% [1] Financial Performance - Total revenue for the first three quarters was RMB 19.89 billion, a decrease of 12.3% compared to the previous year [1] - Net profit attributable to shareholders was RMB 3.511 billion, reflecting a year-on-year decline of 7.1% [1] - Adjusted net profit was RMB 3.079 billion, down 23% year-on-year [1] - Basic earnings per share were RMB 0.3072, a decrease of 4.1% from the same period last year [1] Business Segments - Revenue from the pharmaceutical business was RMB 15.45 billion, down 17.2%, primarily due to centralized procurement and price adjustments in the national medical insurance drug list [1] - Revenue from raw material products was RMB 3.006 billion, an increase of 10.3%, with vitamin C sales reaching RMB 1.788 billion, up 22.3% [1] - Revenue from functional foods and other businesses was RMB 1.435 billion, reflecting an 11.2% increase [1] Research and Development - R&D expenses increased by 7.9% to RMB 4.185 billion, accounting for 27.1% of pharmaceutical business revenue [2] - The company has nearly 90 products in various stages of clinical trials, with 14 submitted for market approval and over 30 key products in the registration clinical phase [2]

Investment Rating - The report rates the nutrition supplement industry in China with a compound annual growth rate (CAGR) of 10.4%, indicating strong growth potential and positioning China as a leading growth engine globally [18][19]. Core Insights - The global nutrition supplement market is expected to grow from $189.2 billion in 2024 to $402.2 billion by 2034, driven by increased health awareness, aging populations, lifestyle changes, and product innovation [6][8]. - China's nutrition supplement market is projected to reach $466 billion by 2034, with significant growth driven by policy support, generational demand, and consumption upgrades [19][20]. - The market is characterized by a shift from standardized products to personalized nutrition strategies, particularly through age and gender-specific formulations [60][71]. Summary by Sections 1. Global and Chinese Nutrition Supplement Market Landscape - The global market is experiencing rapid growth, with a CAGR of 7.8% from 2024 to 2034, influenced by health awareness, aging populations, lifestyle changes, and product innovation [6][10]. - The Asia-Pacific region leads in market share and growth rate, with China achieving a 10% growth rate, making it the most dynamic growth area globally [12][13]. 2. Industry Development Trends and Innovations - The market is transitioning from trend-driven consumption to a more rational, demand-based approach, emphasizing the need for personalized nutrition solutions [43][46]. - There is a notable increase in the demand for probiotics and immune-boosting products, with iron supplements emerging as a star category due to heightened health awareness [39][40]. 3. Consumer Insights on Nutrition Supplement Needs and Behaviors - There is a growing awareness of proactive nutrition among consumers, with six key segments driving rapid demand growth [3][3]. - The market is witnessing a significant shift towards online sales channels, which now dominate with a 56% market share, while traditional channels are declining [22][24]. 4. Future Trends and Opportunities in the Nutrition Supplement Industry - The industry is moving towards precision nutrition and technological innovation, with a focus on multi-dimensional strategies and localized innovations driving brand growth [4][4]. - The report highlights the importance of age and gender-specific nutrition strategies, which are gaining acceptance among consumers, indicating a shift towards more tailored health solutions [60][71].

Group 1: Company Overview - Zhejiang Xinhengcheng Co., Ltd. operates two major platforms: "Chemicals+" and "Biology+" with significant growth potential in both areas [2][3] - The company focuses on a robust R&D system that integrates scientific discovery, technology, and application to enhance product effectiveness [3] Group 2: Financial Performance - In the first three quarters of 2025, the company achieved a total revenue of CNY 16.642 billion, representing a year-on-year growth of 5.45% [3] - The net profit attributable to shareholders reached CNY 5.321 billion, marking a substantial increase of 33.37% compared to the previous year [3] Group 3: Nutritional Products - The nutrition segment is the largest business area, encompassing animal and human nutrition products, including a variety of vitamins and amino acids [3][4] - Key human nutrition products include Vitamin A, D3, E, C, Coenzyme Q10, Taurine, β-Carotene, and Lycopene, with a diverse range of formulations [3] Group 4: Methionine Production - The company has a solid methionine production capacity of 300,000 tons, with an additional 70,000 tons expansion project approved and progressing well [4] - A joint venture with Sinopec for a 180,000 tons/year liquid methionine project is currently undergoing maintenance before resuming production [4] Group 5: Biochemical Fermentation - The company is optimistic about the future of its biochemical fermentation segment, focusing on products like Vitamin C and Coenzyme Q10 [5] - Plans to expand into new products in the fermentation category, including amino acids and new materials, are underway [5] Group 6: Active Pharmaceutical Ingredients - The company specializes in pharmaceutical-grade vitamins and other active pharmaceutical ingredients, providing high-quality raw materials and services to pharmaceutical companies [5] - The company has developed a water-free eye drop formulation that has achieved industry-leading status in treatment efficacy and side effect management [5] Group 7: New Materials Development - The company aims to become a key player in the new materials sector, focusing on high-performance polymers and critical intermediates [5] - The Tianjin nylon new materials project is progressing, with construction initiated in September 2025 [5][6] Group 8: Future Capital Expenditure - Future capital expenditures will be aligned with specific project developments, including the expansion of the PPS project and the establishment of a new flavoring project [6]

Core Viewpoint - The company is actively implementing its "Bio+" strategy by focusing on the development of biotechnological products, particularly in the field of fermentation products, which includes a diverse range of vitamins and amino acids [1] Group 1: Company Strategy - The Heilongjiang base is positioned for the production of bio-fermentation products [1] - The company has laid out a product line that includes Vitamin C, Coenzyme Q10, Vitamin B5, B12, as well as amino acids such as serine, cysteine, and tryptophan [1] - The company emphasizes technological innovation and management improvements to reduce costs and enhance efficiency [1] Group 2: Product Development - The company is committed to expanding its product offerings and improving product utilization through product line diversification and co-design [1] - There is a clear focus on developing new fermentation-based products, aiming to enrich the product matrix in this category [1] - The company is dedicated to building a "Bio+" platform that prioritizes technology in the development of new products [1]

Core Viewpoint - Xinhecheng (002001) is committed to providing safe, healthy, and nutritious products and solutions in the human nutrition sector, with a diverse range of products including vitamins and coenzymes [1] Product Offerings - The main products include Vitamin A, Vitamin D3, Vitamin E, Vitamin C, Coenzyme Q10, Taurine, Beta-Carotene, and Lycopene, showcasing a rich product variety [1] - The company offers customized formulations based on customer needs, indicating flexibility in product development [1] Market Application - Products are widely used in various fields such as health nutrition, baking, confectionery, and beverages, highlighting the versatility of the product applications [1] - The business has a global market presence, providing raw material supply to downstream customers [1]